Adient plc (NYSE:ADNT – Get Free Report) shares gapped up before the market opened on Monday . The stock had previously closed at $24.71, but opened at $25.40. Adient shares last traded at $25.07, with a volume of 63,677 shares trading hands.
Wall Street Analyst Weigh In
Several research analysts have weighed in on the stock. Morgan Stanley decreased their price objective on shares of Adient from $35.00 to $32.00 and set an “underweight” rating for the company in a report on Friday, May 10th. Wells Fargo & Company decreased their price objective on shares of Adient from $33.00 to $32.00 and set an “overweight” rating for the company in a report on Tuesday, June 25th. JPMorgan Chase & Co. decreased their price objective on shares of Adient from $40.00 to $37.00 and set a “neutral” rating for the company in a report on Monday, April 22nd. BNP Paribas raised shares of Adient from an “underperform” rating to a “neutral” rating and set a $26.00 price objective for the company in a report on Monday. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of Adient from $32.00 to $30.00 and set a “hold” rating on the stock in a research report on Monday, May 6th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $37.67.
Read Our Latest Stock Analysis on Adient
Adient Stock Performance
Adient (NYSE:ADNT – Get Free Report) last released its quarterly earnings results on Friday, May 3rd. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.15. Adient had a net margin of 1.04% and a return on equity of 8.72%. The company had revenue of $3.75 billion for the quarter, compared to the consensus estimate of $3.80 billion. During the same period in the previous year, the firm earned $0.32 EPS. Adient’s revenue was down 4.1% on a year-over-year basis. As a group, sell-side analysts anticipate that Adient plc will post 2.26 EPS for the current fiscal year.
Insiders Place Their Bets
In other Adient news, Director Peter Carlin sold 4,207 shares of the business’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $28.90, for a total transaction of $121,582.30. Following the sale, the director now directly owns 28,352 shares in the company, valued at approximately $819,372.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is owned by insiders.
Hedge Funds Weigh In On Adient
Several hedge funds have recently made changes to their positions in ADNT. Partnership Wealth Management LLC acquired a new position in shares of Adient in the 4th quarter worth approximately $83,000. Covestor Ltd increased its position in shares of Adient by 201.5% in the first quarter. Covestor Ltd now owns 3,307 shares of the company’s stock worth $109,000 after acquiring an additional 2,210 shares in the last quarter. Lazard Asset Management LLC purchased a new position in shares of Adient in the first quarter worth approximately $135,000. Headlands Technologies LLC purchased a new position in shares of Adient in the first quarter worth approximately $159,000. Finally, Handelsinvest Investeringsforvaltning purchased a new position in shares of Adient in the fourth quarter worth approximately $207,000. Institutional investors and hedge funds own 92.44% of the company’s stock.
About Adient
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Read More
- Five stocks we like better than Adient
- 5 discounted opportunities for dividend growth investors
- RXO Shares Surge Following New Acquisition Deal
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Bank Stocks – Best Bank Stocks to Invest In
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.